Company: XAIR
Filing Date: 2025-12-11
Form Type: S-1/A
Source: 0001493152-25-027294
Chunk: 26

Company: Beyond Air, Inc.
Filing Date: 2025-12-11
Form: S-1/A
Chunk 26
---
 (ii) | For                                                                                                                                  
 the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus  
 shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities   
 at that time shall be deemed to be the initial bona fide offering thereof.                                                           |

| II-4 |

<div align='center'>EXHIBIT INDEX</div>

| 1.1  
 2.1  |     | At-The-Market Equity Offering Sales Agreement, dated as of February 14, 2025, filed as Exhibit 1.1 to our Current Report on Form 8-K, filed with the SEC on February 14, 2025 and incorporated herein by reference.                                                                                                             
 Agreement and Plan of Merger and Reorganization, dated as of December 29, 2016, by and among AIT Therapeutics, Inc. and Advanced Inhalation Therapies Ltd., filed as Exhibit 2.1 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference.                   |
|:-----|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.2  |     | First Amendment to Agreement and Plan of Merger and Reorganization, dated as of January 12, 2017, by and among AIT Therapeutics, Inc. and Advanced Inhalation Therapies Ltd., filed as Exhibit 2.2 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference. |
| 2.3  |     | Merger Completion Certificate, dated as of December 29, 2016, by and among Red Maple Ltd. And Advance Inhalation (AIT) Ltd., filed as Exhibit 2.3 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference.                                                  |
| 3.1  |     | Amended and Restated Certificate of Incorporation of AIT Therapeutics, Inc., dated as of January 9, 2017, filed as Exhibit 3.1 to our Current Report on Form 8-K, as amended and filed with the SEC on March 15, 2017 and incorporated herein by reference.                                                                     |
| 3.2  |